Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

9.58
Delayed Data
As of Sep 22
 +0.07 / +0.74%
Today’s Change
4.72
Today|||52-Week Range
9.81
+71.07%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close9.51
Today’s open9.79
Day’s range8.76 - 9.81
Volume282,937
Average volume (3 months)132,255
Market cap$245.5M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)-3.24%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratio--
Price/Sales5.59
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
ONVOOrganovo Holdings In...-0.04-1.99%
--Wang On Group Ltd-0.00-50.00%
XBITXBiotech Inc-0.20-4.56%
KMDAKamada Ltd+0.05+1.06%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 21, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Scott T. McMillan
Corporate headquarters
Amsterdam, Noord-holland

Forecasts